05:14
Unknown
Suven Life Sciences (Suven) has received two product patents from USA (8598204 & 8551718) corresponding to the New Chemical Entities (NCEs) for the treatment of disorders associated with Neurodegenerative diseases and these Patents are valid through 2029 and 2030 respectively.
For more information ✆ - 0731-6642300 or Visit http://ift.tt/1doLhaI
Posted in: Indian Market Tips
0 comments:
Post a Comment